<DOC>
	<DOCNO>NCT02072213</DOCNO>
	<brief_summary>Study Investigate The Pharmacokinetics GL2702 GLARS-NF1 Omix Ocas® Healthy Male Volunteers</brief_summary>
	<brief_title>A PK Study GL2702 GLARS-NF1 Omix Ocas® Healthy Male Volunteers</brief_title>
	<detailed_description>GL2702 GLARS-NF1 tablet control release formulation invent GL Pharm Tech Corp .</detailed_description>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>20~45 year old , Healthy Adult Male Subject Body Weight ≥ 50kg Ideal Body Weight ≤ ±20 % ALT AST &gt; 1.25 time ( Upper Normal Range ) Total Bilirubin &gt; 1.5 time ( Upper Normal Range ) CPK &gt; 2 time ( Upper Normal Range ) BUN Creatinine &gt; Normal Range Systolic BP &gt; 160mmHg &lt; 80mmHg , Diastolic BP &gt; 100mmHg &lt; 50mmHg</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Tamsulosin , control release formulation</keyword>
</DOC>